Seth Alpna
SEC CIK 1721020 · EDGAR
BoughtSold
Most active insiders at KROS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneeberger Daniel | 10% | — | $95.66M |
| 2 | Pontifax (China) IV L.P. | 10% | — | $84.98M |
| 3 | Cho Esther | SVP, GC | — | $123.7K |
| 4 | Seehra Jasbir | CEO, Dir | — | $113.4K |
| 5 | Lerner Lorena Raquel | CSO | — | $100.0K |
| 6 | Regnante Keith | CFO | — | $77.5K |
| 7 | BIENAIME JEAN JACQUES | Dir | $75.8K | — |
| 8 | Knowles Julius | Dir | — | $28.2K |
| 9 | Farzan Nima | Dir | — | $28.2K |
| 10 | Seth Alpna | Dir | — | $28.1K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 17:20 | 2026-06-03 | KROS | Keros Therapeutics, Inc. | Seth Alpna | Dir | A - Grant | $0.00 | +7,142 | 12.4K | +136% | $0 |
| T | 2026-06-05 16:15 | 2026-06-04 | KROS | Keros Therapeutics, Inc. | Seth Alpna | Dir | S - Sale | $10.72 | -2,625 | 9,767 | -21% | -$28.1K |
| D | 2025-11-03 | 2025-10-30 | TECH | Bio-Techne | Seth Alpna | Dir | A - Grant | $0.00 | +1,640 | 15.4K | +12% | $0 |
| D | 2025-06-06 | 2025-06-04 | KROS | Keros Therapeutics, Inc. | Seth Alpna | Dir | A - Grant | $0.00 | +5,250 | 5,250 | New | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | Bio-Techne | Seth Alpna | Dir | A - Grant | $0.00 | +1,462 | 13.8K | +12% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | Bio-Techne | Seth Alpna | Dir | A - Grant | $0.00 | +1,625 | 12.3K | +15% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | Bio-Techne | Seth Alpna | Dir | A - Grant | $0.00 | +338 | 2,671 | +14% | $0 |
| D | 2021-11-01 | 2021-10-28 | TECH | Bio-Techne | Seth Alpna | Dir | A - Grant | $0.00 | +194 | 2,333 | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations